Literature DB >> 14637085

Delayed transplantation of fibroblasts genetically modified to secrete BDNF and NT-3 into a spinal cord injury site is associated with limited recovery of function.

J S Shumsky1, C A Tobias, M Tumolo, W D Long, S F Giszter, M Murray.   

Abstract

Delivery of neurotrophic factors in acute models of spinal cord injury in adult rats can rescue axotomized neurons, promote axonal growth, and partially restore function. The extent to which repair and recovery of function can be achieved after chronic injury has received less attention. In the companion paper we show that transplanting fibroblasts genetically modified to produce neurotrophic factors into chronic (6-week) hemisection injuries results in sprouting, partial neuroprotection, but only limited regeneration. Here we describe functional consequences of this treatment using a series of behavioral tests. Adult rats received a complete unilateral C3/C4 hemisection and recovery from the injury was assessed over 5 weeks. At 6 weeks postoperative, the experimental group received grafts of a combination of fibroblasts modified to secrete BDNF or NT-3. The operated control groups received grafts of either gelfoam or gelfoam with fibroblasts expressing GFP into the lesion site. Behavioral recovery in the three groups was assessed over the next 10 weeks. Severe deficits with no recovery in any of the groups were observed in several tests (BBB, limb preference, narrow beam, horizontal rope test) that measure primarily motor function. Recovery was observed in the grid test, a measure of sensorimotor function, and the von Frey test, a measure of response to mechanical stimulation, but there were no differences between the operated control or experimental groups. Both groups also showed recovery from heat-induced hyperalgesia, with the experimental group exhibiting greater recovery than the operated control groups. In this test, delivery of neurotrophic factors from transplanted fibroblasts does not worsen responses to nociceptive stimuli and in fact appears to reduce hypersensitivity. Our data also demonstrate that additional damage to the spinal cord upon placement of a graft further compromises behavioral recovery for locomotor and postural function. Additional therapeutic interventions will be necessary to provide greater levels of recovery after chronic injuries.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14637085     DOI: 10.1016/s0014-4886(03)00398-4

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  39 in total

1.  Aspiration of a cervical spinal contusion injury in preparation for delayed peripheral nerve grafting does not impair forelimb behavior or axon regeneration.

Authors:  Harra R Sandrow; Jed S Shumsky; Arthi Amin; John D Houle
Journal:  Exp Neurol       Date:  2007-12-15       Impact factor: 5.330

2.  Identification of rat respiratory mucosa stem cells and comparison of the early neural differentiation potential with the bone marrow mesenchymal stem cells in vitro.

Authors:  Xin Gao; Jian Zhang; Jun Zhang; Hongjun Zou; Jinbo Liu
Journal:  Cell Mol Neurobiol       Date:  2013-11-30       Impact factor: 5.046

Review 3.  Peripheral nerve grafts support regeneration after spinal cord injury.

Authors:  Marie-Pascale Côté; Arthi A Amin; Veronica J Tom; John D Houle
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

4.  Effect of controlled delivery of neurotrophin-3 from fibrin on spinal cord injury in a long term model.

Authors:  Sara J Taylor; Shelly E Sakiyama-Elbert
Journal:  J Control Release       Date:  2006-07-08       Impact factor: 9.776

5.  Transplants of Neurotrophin-Producing Autologous Fibroblasts Promote Recovery of Treadmill Stepping in the Acute, Sub-Chronic, and Chronic Spinal Cat.

Authors:  Alexander J Krupka; Itzhak Fischer; Michel A Lemay
Journal:  J Neurotrauma       Date:  2016-12-20       Impact factor: 5.269

6.  Implications of poly(N-isopropylacrylamide)-g-poly(ethylene glycol) with codissolved brain-derived neurotrophic factor injectable scaffold on motor function recovery rate following cervical dorsolateral funiculotomy in the rat.

Authors:  Lauren Conova Grous; Jennifer Vernengo; Ying Jin; B Timothy Himes; Jed S Shumsky; Itzhak Fischer; Anthony Lowman
Journal:  J Neurosurg Spine       Date:  2013-04-12

7.  Controlled release of neurotrophin-3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury.

Authors:  Philip J Johnson; Stanley R Parker; Shelly E Sakiyama-Elbert
Journal:  Biotechnol Bioeng       Date:  2009-12-15       Impact factor: 4.530

8.  Forelimb locomotor rating scale for behavioral assessment of recovery after unilateral cervical spinal cord injury in rats.

Authors:  Anita Singh; Laura Krisa; Kelly L Frederick; Harra Sandrow-Feinberg; Sriram Balasubramanian; Scott K Stackhouse; Marion Murray; Jed S Shumsky
Journal:  J Neurosci Methods       Date:  2014-01-24       Impact factor: 2.390

9.  Electro-acupuncture promotes survival, differentiation of the bone marrow mesenchymal stem cells as well as functional recovery in the spinal cord-transected rats.

Authors:  Ying Ding; Qing Yan; Jing-Wen Ruan; Yan-Qing Zhang; Wen-Jie Li; Yu-Jiao Zhang; Yan Li; Hongxin Dong; Yuan-Shan Zeng
Journal:  BMC Neurosci       Date:  2009-04-20       Impact factor: 3.288

10.  Combining peripheral nerve grafts and chondroitinase promotes functional axonal regeneration in the chronically injured spinal cord.

Authors:  Veronica J Tom; Harra R Sandrow-Feinberg; Kassi Miller; Lauren Santi; Theresa Connors; Michel A Lemay; John D Houlé
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.